site-sponsor relationship sample mkt rsch rpt.pptx
TRANSCRIPT
[DATE]
1
Assessing the Quality {Company’s} Rela7onship with its Inves7ga7ve Sites
An Analysis of Company-‐Specific Results From the CenterWatch 2013 Survey of Global InvesBgaBve Sites
SAMPLE CUSTOM MARKET RESEARCH REPORT
Slide #
Survey Methodology 3
A7ributes Measured 4
Execu?ve Summary 7
Importance of Project A7ributes 9
General – Overall Rela?onship Quality Ra?ng 13
{Company Name} – Company-‐Specific Results 19
Reputa?on Ra?ng 99
Respondent Profile 101
2
Table of Contents
3
Survey Methodology The survey instrument used by CenterWatch to measure sponsor-‐site rela?onship quality was conceived in 1997 based on input from representa?ves from sponsor and CRO companies, and inves?ga?ve sites. The survey ques?onnaire was streamlined and op?mized this year. Specifically, a few new project a7ributes were incorporated into the survey this year. Addi?onally, a new ques?on was added reques?ng sites to evaluate sponsor and CRO companies on overall reputa?on in the industry. In the 2011 global survey, Sponsors were evaluated against a total of 29 project a7ributes. In the 2013 global survey, Sponsors were evaluated against a total of 36 project a7ributes. A total of X individual sponsors were evaluated in the 2013 survey due to the overall larger sample size (compared to X CROs in the 2011 survey). For this year’s global survey, the ques?onnaire was e-‐mailed to more than 30,000 sites across the world. A total of 2,032 sites completed the survey, represen?ng a 7% response rate. The majority of respondents originated from North America and Europe. The survey was conducted during the months of November/December 2012 and January 2013. Approximately 72% of the sample were inves?gators, with the remaining sample being study coordinators or administrators. Survey respondents had an average of 12 years clinical research experience. A majority of the global sites conduct clinical research on a part-‐?me basis (57%), while 43% reported full-‐?me involvement in clinical research. In the 2013 survey, X respondents rated their rela?onship quality with {Sponsor Company}.
4
A7ributes Measured OVERALL PROJECT SUPPORT
Timely drug availability
Efficient query handling process
Professional medical staff
Professional administra?ve staff
Staff easily accessible for escala?on of issues & provides ?mely and appropriate resolu?on*
Effec?ve use of communica?on technologies (web portals, IVRS, etc.)*
*New a'ribute in 2013
STUDY MONITORING SUPPORT
Professional, knowledgeable CRAs
Low monitor turnover
Responsive to inquiries
Provides ongoing help in running the study
Is organized and prepared
5
A7ributes Measured
*New a'ribute in 2013
PROTOCOL/STUDY DESIGN & PLANNING
Good overall protocol design
Protocol where ra?onale aligned with clinical prac?ce reali?es
Protocol requires minimal amendments
Realis?c project ?melines
Realis?c pa?ent enrollment goals
Uncomplicated CRF design
Realis?c ?melines for CRF comple?on and return*
INNOVATIVENESS
U?lizes technology to make processes more efficient
Is an innovator in finding ways to improve rela?onships with inves?ga?ve sites*
SITE MANAGEMENT
Adequate training & guidelines for comple?on of CRF*
Adequate training support for trial*
Provides pa?ent recruitment planning & implementa?on assistance
Supports ini?a?ves to build stronger rela?onships with study volunteers*
Holds informa?ve inves?gator mee?ngs
6
A7ributes Measured
*New a'ribute in 2013
WORKSTYLE
Adequately empowers staff to make level-‐appropriate decisions*
Effec?vely works with CROs
Maintains open communica?on
Has a suppor?ve culture
Creates a collabora?ve team environment
CONTRACTS & BUDGETS
Efficient contract & budget nego?a?on
Provides adequate funding for pa?ent recruitment
Is flexible – willing to modify protocols/budgets
Provides prompt payment of grants
Offers realis?c grant payment schedules
Provides fair overall grant payment amounts
7
Execu?ve Summary
• This slide will include an Execu?ve Summary of the survey results for {Sponsor Company}
• What follows are slides with charts detailing the data results for each rela?onship a7ribute
• Reports usually range from 90 – 105 slides
CHART INTERPRETATION
8
14% 18% 11% 9%
39% 35% 42% 36%
44% 44% 44% 53%
76%
0%
20%
40%
60%
80%
100%
Benchmark Company Top-‐Rated Company
2011 Company Ra?ng
Percent Ra?ng Very Important
Excellent
Good
Neutral
Fair
Poor
Percent of Respondents
Ra?ng A7ribute “Very
Important”
A7ribute category
Company ra?ng from
2011 CenterWatch Global Site Survey
Company ra?ng from 2013
CenterWatch Global Site Survey
Top rated company
for a7ribute
Average Sponsor ra?ng
OVERALL PROJECT SUPPORT
SAMPLE DATA